These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 28189578)

  • 1. Meta-Analysis of Soluble Suppression of Tumorigenicity-2 and Prognosis in Acute Heart Failure.
    Aimo A; Vergaro G; Ripoli A; Bayes-Genis A; Pascual Figal DA; de Boer RA; Lassus J; Mebazaa A; Gayat E; Breidthardt T; Sabti Z; Mueller C; Brunner-La Rocca HP; Tang WH; Grodin JL; Zhang Y; Bettencourt P; Maisel AS; Passino C; Januzzi JL; Emdin M
    JACC Heart Fail; 2017 Apr; 5(4):287-296. PubMed ID: 28189578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic Value of Soluble Suppression of Tumorigenicity-2 in Chronic Heart Failure: A Meta-Analysis.
    Aimo A; Vergaro G; Passino C; Ripoli A; Ky B; Miller WL; Bayes-Genis A; Anand I; Januzzi JL; Emdin M
    JACC Heart Fail; 2017 Apr; 5(4):280-286. PubMed ID: 27816512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short-term and long-term prognostic value of circulating soluble suppression of tumorigenicity-2 concentration in acute coronary syndrome: a meta-analysis.
    Gu L; Li J
    Biosci Rep; 2019 Jun; 39(6):. PubMed ID: 31092701
    [No Abstract]   [Full Text] [Related]  

  • 4. The association between soluble suppression of tumorigenicity-2 and long-term prognosis in patients with coronary artery disease: A meta-analysis.
    Liu N; Hang T; Gao X; Yang W; Kong W; Lou Q; Yang J
    PLoS One; 2020; 15(9):e0238775. PubMed ID: 32886697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of Soluble ST2 as a Prognostic Marker in Patients with Acute Heart Failure and Renal Insufficiency.
    Kim MS; Jeong TD; Han SB; Min WK; Kim JJ
    J Korean Med Sci; 2015 May; 30(5):569-75. PubMed ID: 25931787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk stratification with the use of serial N-terminal pro-B-type natriuretic peptide measurements during admission and early after discharge in heart failure patients: post hoc analysis of the PRIMA study.
    Eurlings LW; Sanders-van Wijk S; van Kraaij DJ; van Kimmenade R; Meeder JG; Kamp O; van Dieijen-Visser MP; Tijssen JG; Brunner-La Rocca HP; Pinto YM
    J Card Fail; 2014 Dec; 20(12):881-90. PubMed ID: 25175696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic role of soluble suppression of tumorigenicity-2 on cardiovascular mortality in outpatients with heart failure.
    Gül İ; Yücel O; Zararsız A; Demirpençe Ö; Yücel H; Zorlu A; Yılmaz MB
    Anatol J Cardiol; 2017 Sep; 18(3):200-205. PubMed ID: 28761021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prognostic value of plasma soluble ST2 in hospitalized Chinese patients with heart failure.
    Zhang R; Zhang Y; Zhang J; An T; Huang Y; Guo X; Januzzi JL; Cappola TP; Yin S; Wang Y; Zhou Q; Zou C; Ji S; Lv R
    PLoS One; 2014; 9(10):e110976. PubMed ID: 25347817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of soluble ST2 biomarker in heart failure patients with reduced ejection fraction - A multicenter study.
    Bahuleyan CG; Alummoottil GK; Abdullakutty J; Lordson AJ; Babu S; Krishnakumar VV; Pillai AM; Abraham G; Dilip MN
    Indian Heart J; 2018 Jul; 70 Suppl 1(Suppl 1):S79-S84. PubMed ID: 30122243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic Value of Soluble ST2 After Myocardial Infarction: A Community Perspective.
    Jenkins WS; Roger VL; Jaffe AS; Weston SA; AbouEzzeddine OF; Jiang R; Manemann SM; Enriquez-Sarano M
    Am J Med; 2017 Sep; 130(9):1112.e9-1112.e15. PubMed ID: 28344136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and Prognostic Significance of sST2 in Heart Failure: JACC Review Topic of the Week.
    Aimo A; Januzzi JL; Bayes-Genis A; Vergaro G; Sciarrone P; Passino C; Emdin M
    J Am Coll Cardiol; 2019 Oct; 74(17):2193-2203. PubMed ID: 31648713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soluble ST2 protein and hospitalizations due to worsening chronic heart failure during a one-year follow-up in a population with reduced ejection fraction.
    Wojtczak-Soska K; Sakowicz A; Pietrucha T; Janikowski K; Lelonek M
    Adv Clin Exp Med; 2017 Sep; 26(6):931-938. PubMed ID: 29068593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic and prognostic accuracy of galectin-3 and soluble ST2 for acute heart failure.
    Mueller T; Gegenhuber A; Leitner I; Poelz W; Haltmayer M; Dieplinger B
    Clin Chim Acta; 2016 Dec; 463():158-164. PubMed ID: 27983996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased Plasma Concentrations of Soluble ST2 Independently Predict Mortality but not Cardiovascular Events in Stable Coronary Heart Disease Patients: 13-Year Follow-up of the KAROLA Study.
    Pfetsch V; Sanin V; Jaensch A; Dallmeier D; Mons U; Brenner H; Koenig W; Rothenbacher D
    Cardiovasc Drugs Ther; 2017 Apr; 31(2):167-177. PubMed ID: 28283847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic Value of Serial Measurements of Soluble Suppression of Tumorigenicity 2 and Galectin-3 in Ambulatory Patients With Chronic Heart Failure.
    Miller WL; Saenger AK; Grill DE; Slusser JP; Bayes-Genis A; Jaffe AS
    J Card Fail; 2016 Apr; 22(4):249-55. PubMed ID: 26277907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic and prognostic value of serum soluble suppression of tumorigenicity-2 in heart failure with preserved ejection fraction: A systematic review and meta-analysis.
    Shi Y; Liu J; Liu C; Shuang X; Yang C; Qiao W; Dong G
    Front Cardiovasc Med; 2022; 9():937291. PubMed ID: 36204571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum aldosterone is associated with mortality and re-hospitalization in patients with reduced ejection fraction hospitalized for acute heart failure: analysis from the EVEREST trial.
    Girerd N; Pang PS; Swedberg K; Fought A; Kwasny MJ; Subacius H; Konstam MA; Maggioni A; Gheorghiade M; Zannad F;
    Eur J Heart Fail; 2013 Nov; 15(11):1228-35. PubMed ID: 23787720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemoconcentration is a good prognostic predictor for clinical outcomes in acute heart failure: data from the Korean Heart Failure (KorHF) Registry.
    Oh J; Kang SM; Hong N; Youn JC; Han S; Jeon ES; Cho MC; Kim JJ; Yoo BS; Chae SC; Oh BH; Choi DJ; Lee MM; Ryu KH
    Int J Cardiol; 2013 Oct; 168(5):4739-43. PubMed ID: 23958420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic Value of Baseline and Changes in Circulating Soluble ST2 Levels and the Effects of Nesiritide in Acute Decompensated Heart Failure.
    Tang WH; Wu Y; Grodin JL; Hsu AP; Hernandez AF; Butler J; Metra M; Voors AA; Felker GM; Troughton RW; Mills RM; McMurray JJ; Armstrong PW; O'Connor CM; Starling RC
    JACC Heart Fail; 2016 Jan; 4(1):68-77. PubMed ID: 26656144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation between Levels of Serum Lipoprotein-Associated Phospholipase A2 and Soluble Suppression of Tumorigenicity 2 and Condition of Acute Heart Failure Patients and Their Predictive Value for Prognosis.
    Zhang J; Wang L; Zhao Z; Li L; Xia Y
    J Healthc Eng; 2021; 2021():1525190. PubMed ID: 34956555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.